A Better Treatment For Breast Cancer is Needed As Soon As Possible; See the Situation Now
Even in the field of medicine, a “war” is necessary at times. Since former President Richard Nixon declared “war” on the disease in 1971, our society has placed a strong emphasis on finding ways to reduce the number of people who pass away from cancer. In recent months, Vice President Joe Biden has made sweeping statements and budget proposals that ask Congress for more than $2.8 billion in the federal budget to help advance his cancer-fighting goals. He does this in the hopes of continuing the momentum of the program that was first put forward by former President Barack Obama in 2016.
Patients diagnosed with breast cancer have among the highest percentages of reporting unhappiness with their quality of life. This is likely due to the fact that they have a one in eight risk of obtaining breast cancer throughout their lifetimes, making it one of the most common kinds of cancer in the country.
We require further research, as well as the evaluation of alternative methods of cancer therapy, as well as the creation of novel treatments that take into greater account the quality of life of cancer patients. Therefore, just where is all of that?!
When patients were asked what negatively impacted their quality of life while they were undergoing treatment for cancer, the side effects of therapy were the major and often only response that they gave. This was discovered in one of the first qualitative studies that addressed a patient’s quality of life while they were actively undergoing treatment for cancer.
Surgery, radiation therapy, and chemotherapy each come with their own unique set of adverse effects, some of which include infertility troubles, renal problems, anemia, nausea, infections, and a host of other symptoms. There has been such a successful and daring approach to lowering the mortality rate of breast cancer, but the next frontier of medicine must focus on reducing the adverse effects of our tried and proven cancer medications.
Targeted therapies such as monoclonal antibodies (mAbs), for example, have shown promise as a potentially less harmful alternative to various breast cancer treatments that are now available. mAbs are engineered variants of proteins found naturally in the immune system. They are designed to bind to the HER2 protein found on breast cancer cells and so inhibit the growth of those cells. But here’s the thing.
Despite the fact that there has been a proliferation of clinical studies for the use of monoclonal antibodies (mAbs) to treat breast cancer in recent years, mAbs have not yet realized their full potential, and they are still regarded to be a relatively new therapy.
We need to get the word out about this issue and assist medical professionals in creating new and more effective treatments for cancer patients.
Tiesha loves to share her passion for everything that’s beautiful in this world. Apart from writing on her beauty blog and running her own beauty channel on Youtube, she also enjoys traveling and photography. Tiesha covers various stories on the website.
0 comments